Fix price of stents by March 1, Delhi High Court tells Centre

Published On 2016-12-23 04:27 GMT | Update On 2016-12-23 04:27 GMT

The Delhi High Court on Thursday directed the central government to fix the maximum retail price (MRP) and a ceiling price by March 1, 2017, for coronary stents, used to treat narrowed or weakened arteries in patients.

The order, passed by a division bench of Chief Justice G. Rohini and Justice Sangita Dhingra Sehgal, came a day after coronary stent was notified by the Department of Pharmaceuticals (DoP) as a Schedule-I drug under the Drug Price Control Order (DPCO) 2013, making it eligible for price control.

This means that the National Pharmaceutical Pricing Authority (NPPA) can now start the process of fixing ceiling prices for a variety of stents.

On July 19 this year, the Health Ministry included stents in the National List of Essential Medicines (NLEM) after the court demanded action on a public interest petition filed by advocate Birender Sangwan who sought price control on stents.

The petitioner alleged that the government and the NPPA are being "insensitive and irresponsible" towards the people by not taking any steps to fix the price of the medical device which is allegedly being sold at high price in the country.

It had also claimed that people in all age groups in the country suffer from heart ailments, requiring use of stents and not all of them can afford this treatment.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Fix price of stents by March 1, Delhi High Court tells Centre

Similar News

Is Govt wrong about doctor count in India? RTI reveals severe discrepancy in Parliament, Medical Council data

WBCERC orders hospitals to release bodies within 5 hours, bars withholding over unpaid bills or insurance delays

'Our data's on sale for Rs 3,599'- NEET PG 2025 students allege massive privacy breach

'No court can pass orders contrary to regulations'- HC upholds NMC, University rules on exam attempt limit

Consumer Court clears Lucknow hospital, doctor of medical negligence in bedsore death case

Once patient undergoes treatment, surgery based on doctor's advice, insurer cannot arbitrarily reject claim: Kerala HC

Medical Negligence: Can Hospitals escape liability simply because treatment was provided at no cost?

PG Diploma not equal to PG degree for assistant professor promotions: Himachal HC